Vancity Investment Management Ltd
Position in GILD — Gilead Sciences, Inc.
CIK 1846311
VANCOUVER, A1
Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$240,413
-$9,155,671 QoQ
Shares Held
1,725
-98.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Vancity Investment Management Ltd holds $502,270 across 2 Drug Manufacturers - General names. GILD ranks #2 (47.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,204 | $261,857 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
1,725 | $240,413 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $240,413 | 1,725 | Shares | Sole | 2026-05-15 | |
| 2021-06-30 | $9,396,084 | 136,452 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $8,029,372 | 124,236 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $7,100,612 | 121,878 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||